International Chemical Investors Group (ICIG)

Photo

ICIG Acquires European Advanced Organics Business from Valtris

International Chemical Investors Group (ICIG) has acquired the European Advanced Organics business from Valtris Specialty Chemicals. The transaction includes production plants in Tessenderlo, Belgium, and Maastricht, the Netherlands, as well as the benzyl chloride and derivatives portfolio manufactured at those sites.

Photo

ICIG Wraps up Acquisition of Compounder Benvic

Following all approvals, International Chemical Investors (ICIG) has completed its acquisition of the compounds business of the French Benvic group. The closing follows a binding agreement signed in August.

Photo

ICIG to Acquire MSSA from Nippon Soda

International Chemical Investors Group (ICIG) has entered exclusive negotiations with Nippon Soda and made what it said is a “firm and binding offer” to acquire the Japanese group’s offshoot Métaux Spéciaux (MSSA), a sodium metal specialist.

Photo

Investindustrial Sells PVC Compounder Benvic to ICIG

European private equity group Investindustrial — through subsidiary PVC Europe — has agreed a sale of PVC compounder Benvic to International Chemical Investors Group (ICIG). However, it expects to retain Benvic’s medical activities in Italy.

Photo

CordenPharma Sale Rumors Take Firm Shape

Rumors that German pharmaceutical producer CordenPharma is up for sale have resurfaced following fresh reports that the company’s owner, International Chemical Investors Group (ICIG), plans to formally solicit bids for the business at the end of January.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.